Instil Bio Management

Management criteria checks 3/4

Instil Bio's CEO is Bronson Crouch, appointed in Nov 2018, has a tenure of 5.5 years. total yearly compensation is $1.58M, comprised of 43.4% salary and 56.6% bonuses, including company stock and options. directly owns 1.95% of the company’s shares, worth $1.47M. The average tenure of the management team and the board of directors is 2.9 years and 3.9 years respectively.

Key information

Bronson Crouch

Chief executive officer

US$1.6m

Total compensation

CEO salary percentage43.4%
CEO tenure5.5yrs
CEO ownership2.0%
Management average tenure2.9yrs
Board average tenure3.9yrs

Recent management updates

Recent updates

Instil Bio appoints Tim Moore as COO

Sep 06

We're Keeping An Eye On Instil Bio's (NASDAQ:TIL) Cash Burn Rate

Jul 20
We're Keeping An Eye On Instil Bio's (NASDAQ:TIL) Cash Burn Rate

We're Hopeful That Instil Bio (NASDAQ:TIL) Will Use Its Cash Wisely

Jun 21
We're Hopeful That Instil Bio (NASDAQ:TIL) Will Use Its Cash Wisely

Instil Bio gains on FDA’s orphan drug designation for ITIL-168 in melanoma

Apr 27

CEO Compensation Analysis

How has Bronson Crouch's remuneration changed compared to Instil Bio's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$2mUS$685k

-US$156m

Sep 30 2023n/an/a

-US$197m

Jun 30 2023n/an/a

-US$186m

Mar 31 2023n/an/a

-US$226m

Dec 31 2022US$5mUS$634k

-US$223m

Sep 30 2022n/an/a

-US$225m

Jun 30 2022n/an/a

-US$211m

Mar 31 2022n/an/a

-US$188m

Dec 31 2021US$36mUS$618k

-US$157m

Sep 30 2021n/an/a

-US$119m

Jun 30 2021n/an/a

-US$83m

Mar 31 2021n/an/a

-US$57m

Dec 31 2020US$6mUS$438k

-US$38m

Compensation vs Market: Bronson's total compensation ($USD1.58M) is above average for companies of similar size in the US market ($USD661.60K).

Compensation vs Earnings: Bronson's compensation has been consistent with company performance over the past year.


CEO

Bronson Crouch (50 yo)

5.5yrs

Tenure

US$1,577,289

Compensation

Mr. Bronson Crouch is the Chief Executive Officer and Chairman at Instil Bio, Inc. since November 2018. Mr. Crouch has served as Founding Partner of Curative Ventures Management LLC since January 2014. Mr....


Leadership Team

NamePositionTenureCompensationOwnership
Bronson Crouch
Chairman & CEO5.5yrsUS$1.58m1.95%
$ 1.5m
Sandeep Laumas
CFO & Chief Business Officer3.3yrsUS$922.92k0%
$ 0
Mark Dudley
Chief Scientific Officer2.6yrsno datano data
Robert Hawkins
Head of Research & Development1.4yrsUS$683.57kno data

2.9yrs

Average Tenure

Experienced Management: TIL's management team is considered experienced (2.9 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Bronson Crouch
Chairman & CEO5.5yrsUS$1.58m1.95%
$ 1.5m
Neil Gibson
Lead Independent Non-Employee Director3.9yrsUS$82.65k0%
$ 0
Richard McGaughy
Independent Non-Employee Director3.9yrsUS$66.15k0%
$ 0
Gwendolyn Binder
Independent Non-Employee Director3.8yrsUS$57.15k0%
$ 0
George Matcham
Independent Non-Employee Director5.7yrsUS$57.15k0.59%
$ 441.2k

3.9yrs

Average Tenure

51yo

Average Age

Experienced Board: TIL's board of directors are considered experienced (3.9 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.